KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Teladoc Health (TDOC) over the last 13 years, with Q3 2025 value amounting to $104000.0.

  • Teladoc Health's Gains from Investment Securities fell 9603.2% to $104000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.3 million, marking a year-over-year decrease of 14648.62%. This contributed to the annual value of -$9.8 million for FY2024, which is 23534.13% down from last year.
  • As of Q3 2025, Teladoc Health's Gains from Investment Securities stood at $104000.0, which was down 9603.2% from $7.4 million recorded in Q2 2025.
  • In the past 5 years, Teladoc Health's Gains from Investment Securities ranged from a high of $17.0 million in Q4 2023 and a low of -$17.0 million during Q4 2024
  • Moreover, its 5-year median value for Gains from Investment Securities was $104000.0 (2025), whereas its average is $1.9 million.
  • Over the last 5 years, Teladoc Health's Gains from Investment Securities had its largest YoY gain of 1160245.6% in 2021, and its largest YoY loss of 281672.86% in 2021.
  • Quarter analysis of 5 years shows Teladoc Health's Gains from Investment Securities stood at -$14.6 million in 2021, then surged by 30.82% to -$10.1 million in 2022, then soared by 268.12% to $17.0 million in 2023, then plummeted by 200.18% to -$17.0 million in 2024, then soared by 100.61% to $104000.0 in 2025.
  • Its Gains from Investment Securities stands at $104000.0 for Q3 2025, versus $7.4 million for Q2 2025 and -$1.8 million for Q1 2025.